Titlebook: Endocrine Therapies in Breast and Prostate Cancer; C. Kent Osborne Book 1988 Kluwer Academic Publishers, Boston 1988 carcinoma.cell.clinic

挥舞

978-1-4612-8974-6Kluwer Academic Publishers, Boston 1988

玛瑙

Endocrine Therapies in Breast and Prostate Cancer978-1-4613-1731-9Series ISSN 0927-3042 Series E-ISSN 2509-8497

DEBT

Cancer Treatment and Researchhttp://image.papertrans.cn/e/image/309733.jpg

茁壮成长

Intellectual

kindred

绅士

吊胃口

Representations of Childhood Deathnts, and estrogen therapy may be associated with fluid retention, thromboembolic complications, gynecomastia, and gastrointestinal side effects. Therefore, an effective systemic therapy readily acceptable to all patients and without side effects remains a desirable goal. Antiandrogens are one of sev

nonplus

注意

Preclinical Studies and Antitumor Mechanism of Action of LHRH Analogues,o suppress ovarian activity, reduce circulating levels of estradiol, and cause a decrease in size of estrogen target tissue [5], including an ability to promote extensive regressions in estrogen receptor-positive, dimethylben-zanthracene-induced mammary tumours [6, 7]. Similarly, in male animals, LH